Daiichi Sankyo-B (06996.HK): Hou Bing appointed as Chief Scientific Officer.

date
20/05/2026
Zhitong Finance and Economics App News, Dekui Pharmaceuticals - B (06996.HK) announced that the Board of Directors of the company is pleased to appoint Dr. Hou Bing as Chief Scientific Officer, reporting directly to Dr. Mei Jianming, the founder, Chairman, and CEO of Dekui Pharmaceuticals.